Cargando…
Withdrawal of Gamma-Hydroxybutyrate in a Saudi Male Patient: A Case Report
Gamma-hydroxybutyrate (GHB) is a central nervous system (CNS) depressant with limited clinical use but has been misused in the last few decades. During intoxication, the patient may develop CNS depression and may have agitation, while during withdrawal, the patient can present with severe agitation...
Autores principales: | Alattas, Ibtihal M, Alwajeeh, Sultan A, Alamoudi, Osama O, Alzahrani, Abdulmajeed H, Alhatali, Badria A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729041/ https://www.ncbi.nlm.nih.gov/pubmed/36505956 http://dx.doi.org/10.7759/cureus.32298 |
Ejemplares similares
-
Successful Treatment of Severe Gamma-Hydroxybutyric Acid Withdrawal Syndrome With Dantrolene
por: Röell, Anna Eveline, et al.
Publicado: (2021) -
Treatment of Poorly Responsive Gamma-Hydroxybutyrate Withdrawal With Baclofen: A Case Report
por: Lai, William, et al.
Publicado: (2022) -
The Association Between Abnormal Vital Signs and Mortality in the Emergency Department
por: Simbawa, Jood H, et al.
Publicado: (2021) -
Gamma-hydroxybutyrate withdrawal syndrome: a case report
por: Kuiper, Michael A, et al.
Publicado: (2009) -
The Prevalence of Pediatric Lower Limb Fractures Following Motor Vehicle Accidents at King Abdullah Specialist Children's Hospital, Riyadh, Saudi Arabia
por: Almansouf, Abdulmajeed S, et al.
Publicado: (2022)